Understanding what happens when you discontinue therapy and planning for long-term management can help you keep the results you've worked hard to achieve
Prescribing the same medication to everyone who wants to lose weight, regardless of their biology, is not a functional medicine approach
As more plans accept obesity as a medical condition, insurance coverage for Zepbound grows
The 4mg/3ml Pen (Blue Label) The blue label pen is typically used for individuals who have progressed past the initial starting phases and are now taking a 1mg weekly dose
Phase III trials are now underway, exploring its use not only for obesity but also for sleep apnea and osteoarthritis
For those who are interested in finding out more about semaglutide GLP-1 treatment, including what to expect, how to lower treatment expenses, and the benefits and considerations of this approach, scheduling a consultation session is the next step